药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
5-androstenedione
Guacetisal
The risk or severity of adverse effects can be increased when Guacetisal is combined with Pitolisant.
5-androstenedione
Proglumetacin
The risk or severity of adverse effects can be increased when Proglumetacin is combined with Pitolisant.
5-androstenedione
Propyphenazone
The risk or severity of adverse effects can be increased when Propyphenazone is combined with Pitolisant.
5-androstenedione
Tenidap
The risk or severity of adverse effects can be increased when Tenidap is combined with Pitolisant.
5-androstenedione
Lonazolac
The risk or severity of adverse effects can be increased when Lonazolac is combined with Pitolisant.
5-androstenedione
Nifenazone
The risk or severity of adverse effects can be increased when Nifenazone is combined with Pitolisant.
5-androstenedione
Difenpiramide
The risk or severity of adverse effects can be increased when Difenpiramide is combined with Pitolisant.
5-androstenedione
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Pitolisant.
5-androstenedione
Bumadizone
The risk or severity of adverse effects can be increased when Bumadizone is combined with Pitolisant.
5-androstenedione
Suxibuzone
The risk or severity of adverse effects can be increased when Suxibuzone is combined with Pitolisant.
5-androstenedione
Fentiazac
The risk or severity of adverse effects can be increased when Fentiazac is combined with Pitolisant.
5-androstenedione
Alclofenac
The risk or severity of adverse effects can be increased when Alclofenac is combined with Pitolisant.
5-androstenedione
Tinoridine
The risk or severity of adverse effects can be increased when Tinoridine is combined with Pitolisant.
5-androstenedione
Ebselen
The risk or severity of adverse effects can be increased when Ebselen is combined with Pitolisant.
5-androstenedione
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Pitolisant.
5-androstenedione
Nitroaspirin
The risk or severity of adverse effects can be increased when Nitroaspirin is combined with Pitolisant.
5-androstenedione
Polmacoxib
The risk or severity of adverse effects can be increased when Polmacoxib is combined with Pitolisant.
5-androstenedione
Flunixin
The risk or severity of adverse effects can be increased when Flunixin is combined with Pitolisant.
5-androstenedione
Tepoxalin
The risk or severity of adverse effects can be increased when Tepoxalin is combined with Pitolisant.
5-androstenedione
Robenacoxib
The risk or severity of adverse effects can be increased when Robenacoxib is combined with Pitolisant.